Gemphire Therapeutics Inc. (86) | Separation Agreements (2)
- Separation and Release Agreement entered into on January 16, 2023 by and between NeuroBo Pharmaceuticals, Inc. and Gil Price (Filed With SEC on January 18, 2023)
- Separation Agreement entered into on November 3, 2021 by and between NeuroBo Pharmaceuticals, Inc. and Richard Kang (Filed With SEC on November 4, 2021)
